Bo Wang

Bo Wang

Auto-generated profile, based on publicly available information

Bo Wang

College of Life Science, Xinjiang Agricultural University, Ürümqi, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
LZLi Zhang
Li Zhang
ZCZhimin Cui
Zhimin Cui
QLQianqian Li
Qianqian Li
BWBo Wang
Bo Wang
YYYuanling Yu
Yuanling Yu
YWYouchun Wang
Youchun Wang
Emerging mutations in SARS-CoV-2 cause several waves of COVID-19 pandemic. Here we investigate the infectivity and antigenicity of ten emerging SARS-CoV-2 variants—B.1.1.298, B.1.1.7(Alpha), B.1.351(Beta), P.1(Gamma), P.2(Zeta), B.1.429(Epsilon), B.1.525(Eta), B.1.526-1(Iota), B.1.526-2(Iota), B.1.1.318—and seven corresponding single amino acid mutations in the receptor-binding domain using SARS-CoV-2 pseudovirus. The results indicate that the pseudovirus of most of the SARS-CoV-2 variants (except B.1.1.298) display slightly increased infectivity in human and monkey cell lines, especially B.1.351, B.1.525 and B.1.526 in Calu-3 cells. The K417N/T, N501Y, or E484K-carrying variants exhibit significantly increased abilities to infect mouse ACE2-overexpressing cells. The activities of furin, TMPRSS2, and cathepsin L are increased against most of the variants. RBD amino acid mutations comprising K417T/N, L452R, Y453F, S477N, E484K, and N501Y cause significant immune escape from 11 of 13 monoclonal antibodies. However, the resistance to neutralization by convalescent serum or vaccines elicited serum is mainly caused by the E484K mutation. The convalescent serum from B.1.1.7- and B.1.351-infected patients neutralized the variants themselves better than other SARS-CoV-2 variants. Our study provides insights regarding therapeutic antibodies and vaccines, and highlights the importance of E484K mutation.

3 September 2021 in Cell Research
Verified
Journal Article
Open access
PDF file
HXHua Xu
Hua Xu
BWBo Wang
Bo Wang
TZTian-Ning Zhao
Tian-Ning Zhao
ZLZi-Teng Liang
Zi-Teng Liang
TPTian-Bo Peng
Tian-Bo Peng
XSXiaodong Su
Xiaodong Su

31 October 2022 in Planta
Verified
Journal Article
Closed access
PDF file
XLXiashun Liu
Xiashun Liu
XZXingfeng Zong
Xingfeng Zong
XWXia Wu
Xia Wu
Hao LiuHao Liu
Hao Liu
JHJvdong Han
Jvdong Han
HZHua Zhang
Hua Zhang

1 February 2017 in Journal of Molecular Biology
Verified
Journal Article
Open access
JCJieming Chen
Jieming Chen
BWBo Wang
Bo Wang
LRLynne Regan
Lynne Regan
MGMark Gerstein
Mark Gerstein
Large-scale genome sequencing holds great promise for the interpretation of protein structures through the discovery of many, rare functional variants in the human population. However, because protein-coding regions are under high selective constraints, these variants occur at low frequencies, such that there is often insufficient statistics for downstream calculations. To address this problem, we develop the Intensification approach, which uses the modular structure of repeat protein domains to amplify signals of selection from population genetics and traditional interspecies conservation. In particular, we are able to aggregate variants at the codon level to identify important positions in repeat domains that show strong conservation signals. This allows us to compare conservation over different evolutionary timescales. It also enables us to visualize population-genetic measures on protein structures. We make available the Intensification results as an online resource (http://intensification.gersteinlab.org) and illustrate the approach through a case study on the tetratricopeptide repeat.